When chick embryo fibroblasts infected with high multiplicities of a non-revertible temperature-sensitive (ts) mutant (ts53) of Newcastle disease virus (NDV) at the permissive temperature (34 °C) and incubated to allow the appearance of virus-induced proteins were shifted up to and incubated at the non-permissive temperature (42 °C), analysis of [3H]leucine-labelled proteins by SDS-PAGE revealed a marked increase in cellular protein synthesis and a decline in viral synthesis, with an eventual return to an apparently uninfected state. Mutant ts53 apparently ceased to suppress cellular protein synthesis, and translation of viral proteins was markedly inhibited. This was not observed in ts+-infected cells, or in ts53-infected cells maintained at the permissive temperature. Recovery from the infected state was inhibited by actinomycin D at any stage, but was not prevented by cycloheximide present immediately before and during temperature shift-up. Mutant ts53 was shown to be RNA-at 42 °C, although viral mRNAs synthesized at 34 °C are shown to be present throughout host recovery but in an inactive state.
Mutant ts53 was originally isolated (Dahlberg, 1968) following nitrous acid mutagenesis of the thermostable strain of Newcastle disease virus (NDV), Beaudette C (Granoff, 1959) . The mutation is non-revertible, and previous work has shown an increased susceptibility of the ts53 haemagglutinin-neuraminidase (HN) and matrix (M) proteins to degradation during chase incubation at the non-permissive temperature of 42 °C following labelling at the permissive temperature of 34 °C (Harper et al., 1983) . The status of infected cell protein synthesis subsequent to such a cfiase is examined here.
High titre stocks of ts ÷ and ts53 virions grown in 10-day-old embryonated hens' eggs for 4 days at 34 °C and purified on sucrose/potassium tartrate gradients were used to infect chick embryo fibroblast (CEF) monolayers to monitor protein (Chambers & Samson, 1982) and RNA syntheses in vivo. Pulse-labelling was performed at the indicated temperatures using [3H]leucine (L-[4,5-3H] leucine, Amersham) at 6 laCi per 35 mm diam. monolayer for 30 min, or using [3H]-uridine ([5-3H]uridine, Amersham) at 6 rtCi per monolayer for between 2 and 5 h. Labelling and pre-labelling medium contained leucine at 1 Ixg/ml in all labelling protocols as described previously (Chambers & Samson, 1980) .
Monolayers of 2-day-old secondary CEF were incubated with ts ÷ (at 200 p.f.u./cell), ts53 (at 500 p.f.u./cell), or mock-infected, and incubated as indicated. Monolayers labelled with leucine were, immediately following the pulse, boiled in SDS sample buffer containing 5 ~o 2-mercaptoethanol (Laemmli, 1970) , and analysed on 10~ polyacrylamide gels (Chambers & Samson, 1980) . Monolayers labelled with uridine were treated with ice-cold 5~ TCA for 1 h, taken up in 0.1 M-NaOH, and the total TCA-precipitable counts assayed by liquid scintillation counting. Viral and cellular RNA synthesis was assayed using actinomycin D sensitivity as a differential indicator with correction for actinomycin D-resistant synthesis in uninfected monolayers.
In Fig uninfected cell (lane 3). When, after such an incubation, the medium was replaced with medium at 42 °C and the cells incubated at the higher temperature for 5 h and then labelled with [3H]-leucine, a return to an apparently uninfected state was seen to occur in ts53-infected cells (lane 4). Longer periods (7 or 9 h) at 34 °C prior to temperature shift-up resulted in a lessening of this effect, as shown by increasingly intense viral bands and decreasing host bands (lanes 5, 6). Cells infected with ts ÷ and subjected to 5 h temperature shift-up at 5 h after infection showed no such loss of viral bands (lane 7), and if temperature shift-up was performed at 9 h, cellular lysis was apparent (lane 8). A temperature shift-up of shorter duration resulted in a decreased degree of recovery, as would be expected (data not shown).
This phenomenon, a resurgence of host protein synthesis relative to viral synthesis, which we term host recovery, was therefore examined using a standard protocol of 5 h at 34 °C followed by a temperature shift-up to 42 °C for 5 h prior to leucine labelling at this temperature; this provided a consistently high degree of recovery in ts53-infected cells.
It was found that host recovery during this protocol could be prevented by the use of certain inhibitors (Fig. 2) . When actinomycin D (0.5 ~tg/ml) was present from 0 to 10 h after infection, virus bands were clearly visible (lane 3). This was also the case when actinomycin D was present from 4.75 h post-infection (15 min prior to shift-up) until 10 h (lane 4), although host protein synthesis was, as would be expected, less inhibited. In this experiment, cells exhibiting host recovery did not show total toss of viral protein bands (lane 2). This situation was frequently observed, as a 5 h shift-up was not always sufficient to permit complete recovery. There was always, however, a marked alteration in levels of host and viral protein synthesis. Similar variations have been noted for total protein synthesis in vesicular stomatitis virus (VSV)-infected L cells (Jaye e t al., 1982) . If cycloheximide (50 ~tg/ml) was present from 15 min prior to shift-up to 15 min prior to labelling (i.e. 4.75 to 9.75 h post-infection), host recovery was not prevented (lane 5). Cycloheximide was not added at 0 h, as such treatment led to the prevention of viral secondary transcription, with consequent effects upon viral protein synthesis.
From the above results, it would seem that host recovery requires host-directed R N A synthesis during, and possibly before the shift-up period, but that host-directed protein synthesis is not required subsequent to shift-up. This would seem to suggest the activation, by R N A , of a pre-existing system, possibly synthesized in response to the initial infection, rather than de novo synthesis of such a system following shift-up.
If shift-up was maintained for 10 h (Fig. 3) , ts+-infected cells continued to exhibit viral protein synthesis (lane 1), whereas in ts53-infected cells, host recovery appeared complete (lane 2). If, however, actinomycin D was added 10 h after infection (5 h after shift-up), ts53 proteins were again synthesized by 15 h (lane 3). Thus, it would seem that host-directed R N A synthesis is required to maintain, as well as to initiate, host recovery.
Cells pulse-labelled with [3H]uridine for 2 h in the presence or absence of actinomycin D (0.5 ~tg/ml) were used to assay viral and cellular R N A synthesis prior to and during temperature shift-up (to 42 °C) or in cells maintained at 34 °C (Fig. 4) . In cells remaining at 34 °C (a), both ts + and ts53 exhibited steadily increasing levels of R N A synthesis, but in cells shifted to 42 °U at 5 h (b), ts53-directed R N A synthesis declined, reaching zero by 5 h after shift-up, whereas ts ÷ showed a marked increase followed by a decline when cellular lysis, accelerated by shift-up, became apparent. Cell-directed R N A synthesis at 34 °C or 42 °C (c, d) showed no marked effects, except for the effect of cellular lysis in ts÷-infected cells shifted to 42 °C. The points indicated in Fig. 4 are the midpoints of labelling periods. Thus, it can be seen that ts53 is R N A -at the non-permissive temperature. In view of this, it is apparent that the production of viral proteins following the addition of actinomycin D at the midpoint of a 10 h temperature shift-up must be due to the continued presence of viral m R N A s synthesized prior to host recovery. Further experiments have shown no radical change in total R N A synthesis in the recovering cell, indicating that neither a marked increase in nuclease activity nor a great increase in cell-directed R N A synthesis (which could compete out functional viral mRNAs) has occurred (data not shown).
Taken together, these results suggest that host recovery, occurring when ts53-infected CEF are shifted from the permissive to the non-permissive temperature in the course of infection, requires host-directed de novo R N A synthesis both for initiation and for maintenance of the effect (because sensitivity to actinomycin D is present at all stages), but that no host-directed protein synthesis is required after the shift-up. 
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Mutant ts53 at the permissive temperature appears able to inhibit host cell protein synthesis, but loses this ability at the non-permissive temperature. There is an inhibition of viral protein translation and the cell protein profile returns to the uninfected pattern. This is not observed in ts+-infected cells at either temperature.
Other ts mutants that are RNA ÷ studied in this laboratory do not fail to synthesize viral proteins at the non-permissive temperature. Strain ts53 was used in these studies because of its non-revertible, non-leaky mutation, which makes control of its intracellular activities relatively simple. It is thus suitable for elucidation of the effects studied here, which may be of wider import.
It can be seen that host recovery involves a temporary (rather than a permanent) inactivation of viral mRNAs, and shows its effects at the level of their translation. Similar effects on relative levels of protein synthesis have recently been observed in VSV-infected cultured human cells treated with homologous or-interferon (Masters & Samuel, 1983) . Preliminary experiments have shown the presence of an agent transferable in the medium which reduces [3H]uridine incorporation by ts ÷ challenge virus (NDV) when CEF monolayers are treated with medium from ts53-infected cell cultures. Furthermore, it is known that the early cellular response to c~ or fl interferon is not prevented by cycloheximide and that an antiviral state develops rapidly once the inhibitor is removed, but that this response is prevented by actinomycin D (Dianzani et al., 1980; Baglioni & Maroney, 1980) . It would thus appear possible that an autocrine process involving interferon may be involved in the effects reported, and that in ts53 infection this response becomes apparent following shift-up to the non-permissive temperature. D.R.H. is the recipient of a S.E.R.C. postgraduate award.
